Header Logo

Connection

DOUGLAS J HARRISON to Quinazolines

Back to Details
This is a "connection" page, showing publications DOUGLAS J HARRISON has written about Quinazolines.
DOUGLAS J HARRISON
Connection Strength
0.153
Quinazolines
  1. Evaluation of the pan-class I phosphoinositide 3-kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma. Pediatr Blood Cancer. 2023 Jan; 70(1):e30017.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.